Eli Lilly And Company (LLY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Core Strategy - The company has undertaken a significant reboot of its R&D strategy in oncology to enhance productivity and sustainability within the organization [2] Historical Context - Historically, the company has developed and marketed several important medicines in oncology, including chemotherapies [2]